Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
暂无分享,去创建一个
A. Burt | C. Day | S. McPherson | E. Henderson | S. Stewart
[1] V. Basevi. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[2] Julien Vergniol,et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease , 2010, Hepatology.
[3] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[4] A. Sanyal,et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] A. Feldstein,et al. Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.
[6] S. Caldwell,et al. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.
[7] V. Rigalleau,et al. 989 NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI ≥ 30 kg/m2 , 2009 .
[8] B. Neuschwander‐Tetri,et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease , 2008, Gut.
[9] I. Guha,et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.
[10] M. Shiffman,et al. Percutaneous liver biopsy in clinical practice , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[11] S. Pol,et al. FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest , 2007, Hepatology.
[12] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[13] Dominique Thabut,et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.
[14] M. Holmqvist,et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.
[15] V. de Lédinghen,et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.
[16] Shi-yao Chen,et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.
[17] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[18] C. Day. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. , 2005, Gastroenterology.
[19] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[20] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[21] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[22] E. Fassio,et al. Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies , 2004, Hepatology.
[23] James G Kench,et al. Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.
[24] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[25] P. Giral,et al. Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.
[26] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[27] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[28] M. Bennett,et al. The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.
[29] M. Bennett,et al. The natural history of nonalcoholic fatty liver: A follow‐up study , 1995, Hepatology.
[30] I. Wanless,et al. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.
[31] J. Hoofnagle,et al. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. , 1988, Gastroenterology.